The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
Feb 14, 2025•over 1 year ago
Contract Type
agreement
Mountain ViewHealthcare
Description
NeuroPace, Inc. has announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $10.00 per share, resulting in expected aggregate gross proceeds of $65 million before deductions.
Company Information
Company
NeuroPace
Location
455 N. BERNARDO AVENUE
Mountain View, California, United States
About
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Mountain ViewHealthcare